Insider · CIK 0001822092

Oliger Christy J.

Reports to the SEC for 10 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001822092

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-01	ZBIOZenas BioPharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+37K sh	—	—	37,000
2026-07-28	BCAXBicara Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+39K sh	—	—	38,950
2026-07-15	NUVLNuvalent, Inc.U Disposition from Tender	Director	UDisposition from Tender	−1,324 sh	$124.00	−$164K	0
2026-07-15	NUVLNuvalent, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−6,091 sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,119 sh	—	—	0
2026-06-16	NUVLNuvalent, Inc.A Award	Director	AAward	+3,444 sh	—	—	7,415
2026-05-21	VERAVera Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.1K sh	—	—	17,084
2026-05-21	KPTIKaryopharm Therapeutics Inc.A Award	Director	AAward	+15.5K sh	—	—	15,508
2026-04-01	REPLReplimune Group, Inc. · Stock Option (right to buy)A Award	Director	AAward	+44.5K sh	—	—	44,500
2025-11-13	LAVA Therapeutics NVShare Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−33.4K sh	—	—	0
2025-06-18	NUVLNuvalent, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,119 sh	—	—	6,119
2025-06-18	NUVLNuvalent, Inc.A Award	Director	AAward	+3,971 sh	—	—	3,971
2025-05-28	KPTIKaryopharm Therapeutics Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+4,600 sh	—	—	4,600
2025-05-14	VERAVera Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,000
2025-04-01	REPLReplimune Group, Inc. · Stock Option (right to buy)A Award	Director	AAward	+32K sh	—	—	32,000
2025-02-13	LAVA Therapeutics NVCommon Shares (Right to Buy)A Award	Director	AAward	+33.4K sh	—	—	33,390
2024-06-07	VERAVera Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2024-05-29	KPTIKaryopharm Therapeutics Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+69K sh	—	—	69,000
2024-04-01	REPLReplimune Group, Inc. · Stock Option (right to buy)A Award	Director	AAward	+32K sh	—	—	32,000
2024-02-26	RayzeBio, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−115K sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−106 sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,137 sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,620 sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−180 sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCD Disposition to Issuer	Director	DDisposition to Issuer	−5,565 sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,250 sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2023-06-07	REATA PHARMACEUTICALS INCStock Option (right-to-buy)A Award	Director	AAward	+2,137 sh	—	—	2,137
2023-06-07	REATA PHARMACEUTICALS INCA Award	Director	AAward	+1,682 sh	$93.61	+$157K	5,565
2023-05-24	KPTIKaryopharm Therapeutics Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+34K sh	—	—	34,000
2023-04-01	REPLReplimune Group, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25.2K sh	—	—	25,200
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18K sh	—	—	0
2022-06-08	REATA PHARMACEUTICALS INCA Award	Director	AAward	+3,883 sh	$34.76	+$135K	3,883
2022-06-08	REATA PHARMACEUTICALS INCStock Option (right-to-buy)A Award	Director	AAward	+5,620 sh	—	—	5,620
2022-05-19	KPTIKaryopharm Therapeutics Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+23.9K sh	—	—	23,900
2022-04-01	REPLReplimune Group, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.5K sh	—	—	16,500
2021-12-01	REPLReplimune Group, Inc. · Stock Option (right to buy)A Award	Director	AAward	+33K sh	—	—	33,000
2021-06-10	REATA PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+180 sh	$83.24	+$15K	180
2021-06-10	REATA PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2021-06-02	Sierra Oncology, Inc.Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2021-05-21	KPTIKaryopharm Therapeutics Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+23.9K sh	—	—	23,900
2021-04-15	REATA PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+106 sh	$52.85	+$5,602.1	106
2021-04-15	REATA PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-04-15	REATA PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+1,250 sh	—	—	1,250
2020-08-28	KPTIKaryopharm Therapeutics Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+32.8K sh	—	—	32,800

Recent filings

Accepted (ET)
Sep 24
Oliger Christy J.0001104659-26-104728
SEC(opens sec.gov)
Jul 294
Oliger Christy J.0001470831-26-000737
SEC(opens sec.gov)
Jul 154
Oliger Christy J.0001193125-26-305081
SEC(opens sec.gov)
Jun 184
Oliger Christy J.0001822092-26-000007
SEC(opens sec.gov)
May 264
Oliger Christy J.0001822092-26-000004
SEC(opens sec.gov)
May 264
Oliger Christy J.0001822092-26-000005
SEC(opens sec.gov)
Apr 74
Oliger Christy J.0001104659-26-040576
SEC(opens sec.gov)
Nov 174
Oliger Christy J.0001822092-25-000005
SEC(opens sec.gov)
Jun 204
Oliger Christy J.0000950170-25-088544
SEC(opens sec.gov)
May 294
Oliger Christy J.0000950170-25-078956
SEC(opens sec.gov)
May 164
Oliger Christy J.0001415889-25-013420
SEC(opens sec.gov)
Apr 34
Oliger Christy J.0001104659-25-031825
SEC(opens sec.gov)
Feb 184
Oliger Christy J.0001415889-25-004524
SEC(opens sec.gov)
Jun 114
Oliger Christy J.0001415889-24-016358
SEC(opens sec.gov)
May 304
Oliger Christy J.0000950170-24-066784
SEC(opens sec.gov)
Apr 34
Oliger Christy J.0001104659-24-043248
SEC(opens sec.gov)
Feb 274
Oliger Christy J.0001415889-24-005551
SEC(opens sec.gov)

Companies

Address

C/O ZENAS BIOPHARMA, INC. 852 WINTER ST., SUITE 250

WALTHAM, MA, 02451